239 related articles for article (PubMed ID: 33966155)
41. Comparison between breast MRI and contrast-enhanced spectral mammography.
Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
[TBL] [Abstract][Full Text] [Related]
42. Association between lesion enhancement and breast cancer in contrast-enhanced spectral mammography.
Boy FNS; Goksu K; Tasdelen I
Acta Radiol; 2023 Jan; 64(1):74-79. PubMed ID: 34854742
[TBL] [Abstract][Full Text] [Related]
43. Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
Fallenberg EM; Dromain C; Diekmann F; Renz DM; Amer H; Ingold-Heppner B; Neumann AU; Winzer KJ; Bick U; Hamm B; Engelken F
Breast Cancer Res Treat; 2014 Jul; 146(2):371-81. PubMed ID: 24986697
[TBL] [Abstract][Full Text] [Related]
44. Practical uses of contrast-enhanced spectral mammography in daily work: A pictorial review.
Alexander S; Dulku G; Hashoul S; Taylor DB
J Med Imaging Radiat Oncol; 2019 Aug; 63(4):473-478. PubMed ID: 31332941
[TBL] [Abstract][Full Text] [Related]
45. Breast Radiation Dose With CESM Compared With 2D FFDM and 3D Tomosynthesis Mammography.
James JR; Pavlicek W; Hanson JA; Boltz TF; Patel BK
AJR Am J Roentgenol; 2017 Feb; 208(2):362-372. PubMed ID: 28112559
[TBL] [Abstract][Full Text] [Related]
46. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
Tang S; Xiang C; Yang Q
Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
[TBL] [Abstract][Full Text] [Related]
47. Attention-based deep learning for breast lesions classification on contrast enhanced spectral mammography: a multicentre study.
Mao N; Zhang H; Dai Y; Li Q; Lin F; Gao J; Zheng T; Zhao F; Xie H; Xu C; Ma H
Br J Cancer; 2023 Mar; 128(5):793-804. PubMed ID: 36522478
[TBL] [Abstract][Full Text] [Related]
48. The impact of contrast-enhanced spectral mammogram (CESM) and three-dimensional breast ultrasound (3DUS) on the characterization of the disease extend in cancer patients.
Helal MH; Mansour SM; Salaleldin LA; Alkalaawy BM; Salem DS; Mokhtar NM
Br J Radiol; 2018 Jul; 91(1087):20170977. PubMed ID: 29641226
[TBL] [Abstract][Full Text] [Related]
49. Angiomammography: A review of current evidences.
Dromain C; Vietti-Violi N; Meuwly JY
Diagn Interv Imaging; 2019 Oct; 100(10):593-605. PubMed ID: 30962168
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria.
Lalji UC; Jeukens CR; Houben I; Nelemans PJ; van Engen RE; van Wylick E; Beets-Tan RG; Wildberger JE; Paulis LE; Lobbes MB
Eur Radiol; 2015 Oct; 25(10):2813-20. PubMed ID: 25813015
[TBL] [Abstract][Full Text] [Related]
51. Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy.
James J
Br J Radiol; 2022 Apr; 95(1132):20211287. PubMed ID: 35015574
[TBL] [Abstract][Full Text] [Related]
52. Contrast mammography in clinical practice: Current uses and potential diagnostic dilemmas.
Zamora K; Allen E; Hermecz B
Clin Imaging; 2021 Mar; 71():126-135. PubMed ID: 33197726
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic performance of dual-energy contrast-enhanced subtracted mammography in dense breasts compared to mammography alone: interobserver blind-reading analysis.
Cheung YC; Lin YC; Wan YL; Yeow KM; Huang PC; Lo YF; Tsai HP; Ueng SH; Chang CJ
Eur Radiol; 2014 Oct; 24(10):2394-403. PubMed ID: 24928280
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis.
Suter MB; Pesapane F; Agazzi GM; Gagliardi T; Nigro O; Bozzini A; Priolo F; Penco S; Cassano E; Chini C; Squizzato A
Breast; 2020 Oct; 53():8-17. PubMed ID: 32540554
[TBL] [Abstract][Full Text] [Related]
55. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
[TBL] [Abstract][Full Text] [Related]
56. Staging of breast cancer and the advanced applications of digital mammogram: what the physician needs to know?
Helal MH; Mansour SM; Zaglol M; Salaleldin LA; Nada OM; Haggag MA
Br J Radiol; 2017 Mar; 90(1071):20160717. PubMed ID: 28055247
[TBL] [Abstract][Full Text] [Related]
57. Dual-energy contrast-enhanced spectral mammography (CESM).
Daniaux M; De Zordo T; Santner W; Amort B; Koppelstätter F; Jaschke W; Dromain C; Oberaigner W; Hubalek M; Marth C
Arch Gynecol Obstet; 2015 Oct; 292(4):739-47. PubMed ID: 25814297
[TBL] [Abstract][Full Text] [Related]
58. A twin convolutional neural network with hybrid binary optimizer for multimodal breast cancer digital image classification.
Oyelade ON; Irunokhai EA; Wang H
Sci Rep; 2024 Jan; 14(1):692. PubMed ID: 38184742
[TBL] [Abstract][Full Text] [Related]
59. Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
Wessling D; Männlin S; Schwarz R; Hagen F; Brendlin A; Olthof SC; Hattermann V; Gassenmaier S; Herrmann J; Preibsch H
Eur Radiol; 2023 Apr; 33(4):2945-2953. PubMed ID: 36474057
[TBL] [Abstract][Full Text] [Related]
60. Costing analysis to introduce a contrast-enhanced mammography service to replace an existing breast MRI service for local staging of breast cancer.
Savaridas SL; Jin H
Clin Radiol; 2023 May; 78(5):340-346. PubMed ID: 36804270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
